External links [edit] Official website Novo Nordisk Inc Novo Nordisk Pharmatech A/S Business data for Novo Nordisk: Novo Nordisk 1923 establishments in Denmark Biotechnology companies of Denmark Companies based in Gladsaxe Municipality Companies listed on Nasdaq Copenhagen Companies listed on the New York Stock Exchange Companies in the OMX Nordic 40 Companies in the S&P Europe 350 Dividend Aristocrats Danish brands Danish companies established in 1923 Health care companies of Denmark Life science companies based in Copenhagen Life sciences industry Pharmaceutical companies established in 1923 Pharmaceutical companies of Denmark Companies in the OMX Copenhagen 25

Physicians should avoid prescribing to: Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Individuals with severe gastrointestinal disorders (such as gastroparesis) Patients with a known hypersensitivity to GLP-1 or GIP receptor agonists Pregnant or breastfeeding women, unless deemed necessary by a healthcare provider Potential Side Effects Like any medication, this may cause side effects, though most are mild and transient. Common Side Effects (Usually Improve Over Time) Mild nausea (most common, usually decreases after the first few weeks) Vomiting or diarrhea in some cases, especially during dose escalation Constipation or bloating as digestion slows Mild fatigue or headaches as the body adjusts Less Common But Serious Side Effects Severe gastrointestinal distress (persistent nausea, vomiting, or diarrhea requiring discontinuation) Pancreatitis (rare) Monitor for severe abdominal pain Hypoglycemia (rare in non-diabetics) May occur if combined with other insulin-stimulating agents Allergic reactions (very rare) Swelling, rash, or difficulty breathing Physicians should titrate doses gradually to minimize side effects and improve patient tolerance

For a wider overview, visit our GLP-1 medication guide and injection therapy tracking guide
Why does PlexusDx charge a flat monthly rate rather than pricing by dose
Patients should follow provider instructions carefully and understand that compounded products are not FDA-approved drug products
The serum zinc concentration was initially low for leukemia patients undergoing allogeneic bone marrow transplantation